Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID)

Journal of Clinical Immunology

Volumn 38, Issue 3, 2018, Pages 225-233

  Lawrence, Monica G ^a   Palacios Kibler, Thamiris V ^a   Workman, Lisa J ^a   Schuyler, Alexander J ^a   Steinke, John W ^a   Payne, Spencer C ^a,b   McGowan, Emily C ^a,c   Patrie, James ^b   Fuleihan, Ramsay L ^d   Sullivan, Kathleen E ^e   Lugar, Patricia L ^f   Hernandez, Camellia L ^g   Beakes, Douglas E ^g   Verbsky, James W ^h   Platts Mills, Thomas A E ^a   Cunningham Rundles, Charlotte ⁱ   Routes, John M ^h   Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Common variable immunodeficiency; IgE; IgE deficiency; secondary hypogammaglobulinemia

Indexed keywords

IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; ALLERGEN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIZATION; HUMAN; ICD-10; ICD-9; IMMUNOGLOBULIN DEFICIENCY; LIMIT OF QUANTITATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTITUTION THERAPY; ADOLESCENT; BLOOD; FEMALE; IMMUNIZATION; IMMUNOLOGY; MALE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; ALLERGENS; BIOMARKERS; CHILD; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MALE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85042102022     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-018-0476-0     Document Type: Article

References (38)

1. Seppanen M, Aghamohammadi A, Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? Expert Rev Clin Immunol. 2014;10(1):1–5. 10.1586/1744666X.2014.870478.
2. Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev. 2006;5(2):156–9. 10.1016/j.autrev.2005.10.002.
3. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59. 10.1016/j.jaip.2015.07.025.
4. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–86. 10.1182/blood-2007-11-124545.
5. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145(6):709–27. 10.1111/j.1365-2141.2009.07669.x.
6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48. 10.1006/clim.1999.4725.
7. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol. 2010;137(1):21–30. 10.1016/j.clim.2010.06.012.
8. Orange JS, Ochs HD, Cunningham-Rundles C. Prioritization of evidence-based indications for intravenous immunoglobulin. J Clin Immunol. 2013;33(6):1033–6. 10.1007/s10875-013-9912-3.
9. Stites DP, Ishizaka K, Fudenberg HH. Serum IgE concentrations in hypogammaglobulinaemia and selective IgA deficiency. Studies on patients and family members. Clin Exp Immunol. 1972;10(3):391–7.
10. Waldmann TA, Polmar SH, Balestra ST, Jost MC, Bruce RM, Terry WD. Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome. J Immunol. 1972;109(2):304–10.
11. McLaughlan P, Stanworth DR, Webster AD, Asherson GL. Serum IgE in immune deficiency disorders. Clin Exp Immunol. 1974;16(3):375–81.
12. Iio A, Strober W, Broder S, Polmar SH. The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J Clin Invest. 1977;59(5):743–55. 10.1172/JCI108695.
13. Agondi RC, Barros MT, Kokron CM, Cohon A, Oliveira AK, Kalil J, et al. Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy. 2013;27(2):79–83. 10.2500/ajra.2013.27.3855.
14. Agondi RC, Barros MT, Rizzo LV, Kalil J, Giavina-Bianchi P. Allergic asthma in patients with common variable immunodeficiency. Allergy. 2010;65(4):510–5. 10.1111/j.1398-9995.2009.02211.x.
15. Unsworth DJ, Virgo PF, Lock RJ. Immunoglobulin E deficiency: a forgotten clue pointing to possible immunodeficiency? Ann Clin Biochem. 2011;48(Pt 5):459–61. 10.1258/acb.2011.011052.
16. Hartman H, Schneider K, Hintermeyer M, Bausch-Jurken M, Fuleihan R, Sullivan KE, et al. Lack of clinical hypersensitivity to penicillin antibiotics in common variable immunodeficiency. J Clin Immunol. 2017;37(1):22–4. 10.1007/s10875-016-0353-7.
17. Perzanowski MS, Ronmark E, James HR, Hedman L, Schuyler AJ, Bjerg A, et al. Relevance of specific IgE antibody titer to the prevalence, severity, and persistence of asthma among 19-year-olds in northern Sweden. J Allergy Clin Immunol. 2016;138(6):1582–90. 10.1016/j.jaci.2016.05.017.
18. Salo PM, Arbes SJ Jr, Jaramillo R, Calatroni A, Weir CH, Sever ML, et al. Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006. J Allergy Clin Immunol. 2014;134(2):350–9. 10.1016/j.jaci.2013.12.1071.
19. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8. 10.1136/jech-2013-203104.
20. Gergen PJ, Arbes SJ Jr, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2009;124(3):447–53. 10.1016/j.jaci.2009.06.011.
21. Smith JK, Krishnaswamy GH, Dykes R, Reynolds S, Berk SL. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol. 1997;78(3):313–8. 10.1016/S1081-1206(10)63188-2.
22. Levin TA, Ownby DR, Smith PH, Peterson EL, Williams LK, Ford J, et al. Relationship between extremely low total serum IgE levels and rhinosinusitis. Ann Allergy Asthma Immunol. 2006;97(5):650–2. 10.1016/S1081-1206(10)61095-2.
23. Magen E, Schlesinger M, David M, Ben-Zion I, Vardy D. Selective IgE deficiency, immune dysregulation, and autoimmunity. Allergy Asthma Proc. 2014;35(2):e27–33. 10.2500/aap.2014.35.3734.
24. Looney TJ, Lee JY, Roskin KM, Hoh RA, King J, Glanville J, et al. Human B-cell isotype switching origins of IgE. J Allergy Clin Immunol. 2016;137(2):579–86 e7. 10.1016/j.jaci.2015.07.014.
25. Kubo S, Nakayama T, Matsuoka K, Yonekawa H, Karasuyama H. Long term maintenance of IgE-mediated memory in mast cells in the absence of detectable serum IgE. J Immunol. 2003;170(2):775–80. 10.4049/jimmunol.170.2.775.
26. Lawrence MG, Woodfolk JA, Schuyler AJ, Stillman LC, Chapman MD, Platts-Mills TA. Half-life of IgE in serum and skin: consequences for anti-IgE therapy in patients with allergic disease. J Allergy Clin Immunol. 2017;139(2):422–8 e4. 10.1016/j.jaci.2016.04.056.
27. Rachid R, Castells M, Cunningham-Rundles C, Bonilla FA. Association of anti-IgA antibodies with adverse reactions to gamma-globulin infusion. J Allergy Clin Immunol. 2011;128(1):228–30 e1. 10.1016/j.jaci.2011.01.061.
28. Gurcan HM, Keskin DB, Ahmed AR. Information for healthcare providers on general features of IGIV with emphasis on differences between commercially available products. Autoimmun Rev. 2010;9(8):553–9. 10.1016/j.autrev.2010.03.003.
29. Paganelli R, Quinti I, D'Offizi GP, Papetti C, Cabello A, Aiuti F. A study of IgE in immunoglobulin preparations for intravenous administration. I. IgE in intravenous IgG. Vox Sang. 1986;51(2):87–91. 10.1111/j.1423-0410.1986.tb00220.x.
30. Tovo PA, Gabiano C, Grazia Roncarolo M, Altare F. IgE content of commercial intravenous IgG preparations. Lancet. 1984;1(8374):458.
31. Newland AC, Macey MG, Bubel M. IgE in intravenous IgG. Lancet. 1984;1(8391):1406–7.
32. Stephan W, Dichtelmuller H. IgE in immunoglobulin for intravenous use. Lancet. 1984;1(8382):912.
33. Levy Y, Nakum A, Segal N, Monselise Y, Danon YL. The association of selective IgA deficiency and IgE hypogammaglobulinemia. Allergy. 2005;60(6):836–8. 10.1111/j.1398-9995.2005.00799.x.
34. Flanagan JG, Rabbitts TH. Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes. Nature. 1982;300(5894):709–13. 10.1038/300709a0.
35. Aan de Kerk DJ, Jansen MH, Jolles S, Warnatz K, Seneviratne SL, Ten Berge IJ, et al. Phenotypic and functional comparison of class switch recombination deficiencies with a subgroup of common variable immunodeficiencies. J Clin Immunol. 2016;36(7):656–66. 10.1007/s10875-016-0321-2.
36. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117(4):740–6; quiz 7. 10.1016/j.jaci.2006.01.038.
37. Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726. 10.1007/s10875-015-0201-1.
38. Magen E, Schlesinger M, Ben-Zion I, Vardy D. Helicobacter pylori infection in patients with selective immunoglobulin E deficiency. World J Gastroenterol. 2015;21(1):240–5. 10.3748/wjg.v21.i1.240.